GICS Sector : Healthcare
Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies.The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows integrations with third-party applications and sensors.It also provides COVID-19 testing kits for the Cue Health Monitoring System The company was formerly known as Cue Inc and changed its name to Cue Health Inc.
Unfortunately this company is not part of our coverage yet. But as part of your subscription plan you can request it by clicking just below and we'll process.
Verizon Business returns to HLTH 2024 to showcase how 5G innovation drives the future of healthcare
Oct -17
TeleVox Showcases Latest Patient Relationship Management Innovations at HLTH 2024
Oct -16
UniDoc Health to Attend HLTH 2024 as Part of S&P500 TelCo's Booth
Oct -02
Why Is Cue Health (HLTH) Stock Up 99% Today?
May -30
Why Is Cue Health (HLTH) Stock Down 40% Today?
May -29
Cue Health to Pursue Wind Down of the Business
May -28
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
May -20
Cue Health Evaluating Warning Letter Received from Food and Drug Administration (FDA)
May -14
Cue Integrated Care Platform's 23.98% growth is driven by increasing adoption of at-home COVID-19 testing, growing demand for decentralized healthcare, and expansion into new markets. Additionally, Cue Health's AI-powered diagnostic capabilities, user-friendly interface, and partnerships with healthcare providers and governments contribute to its rapid growth.
Cue Health Inc.'s 10.9% growth in Grant and Other is driven by increasing government funding for COVID-19 testing and diagnostics, expansion into new markets, and strategic partnerships with healthcare providers and research institutions. Additionally, the company's innovative molecular diagnostic platform and growing demand for at-home testing solutions contribute to its rapid growth.
A molecular diagnostic test kit that detects the presence of SARS-CoV-2, the virus that causes COVID-19, in individuals suspected of having the virus.
A connected health platform that integrates with Cue's COVID-19 Test Kit, providing users with a comprehensive health monitoring system.
A portable, handheld device that reads and interprets Cue's COVID-19 Test Kit results, providing accurate and rapid diagnosis.
Single-use cartridges that contain the necessary reagents and materials for Cue's COVID-19 Test Kit.
Cue Health Inc. has a low threat of substitutes due to its unique molecular diagnostic technology, which provides accurate and rapid results.
Cue Health Inc. has a medium bargaining power of customers due to the presence of a few large customers, but the company's unique technology and strong brand reputation mitigate this power.
Cue Health Inc. has a low bargaining power of suppliers due to its ability to source high-quality components and materials from multiple suppliers, reducing dependence on any one supplier.
Cue Health Inc. has a high threat of new entrants due to the growing demand for molecular diagnostic technologies and the potential for new companies to enter the market with innovative solutions.
Cue Health Inc. operates in a moderately competitive market, with a few established players and some new entrants, but the company's unique technology and strong brand reputation help to differentiate it from competitors.
| Value | |
|---|---|
| Debt Weight | 16.08% |
| Debt Cost | 3.95% |
| Equity Weight | 83.92% |
| Equity Cost | 10.45% |
| WACC | 9.40% |
| Leverage | 19.16% |
Value: 7.5
Growth: 3.0
Quality: 5.1
Yield: 0.0
Momentum: 9.5
Volatility: 5.3
1-Year Total Return ->
Value: 8.7
Growth: 5.3
Quality: 4.1
Yield: 0.0
Momentum: 2.5
Volatility: 2.3
1-Year Total Return ->
Value: 10.0
Growth: 3.2
Quality: 3.6
Yield: 0.0
Momentum: 5.0
Volatility: 0.0
1-Year Total Return ->
Value: 8.0
Growth: 3.6
Quality: 4.3
Yield: 0.0
Momentum: 5.0
Volatility: 0.7
1-Year Total Return ->
Value: 9.6
Growth: 3.9
Quality: 4.3
Yield: 0.0
Momentum: 1.0
Volatility: 2.0
1-Year Total Return ->
Value: 10.0
Growth: 4.1
Quality: 3.4
Yield: 0.0
Momentum: 0.0
Volatility: 0.0
1-Year Total Return ->